Novo says Ozempic shows lower risk of cardiovascular events compared to Lilly's Mounjaro

Technology By Reuters • September 29, 2026, 5:28 PM UTC
⏱ 1 min read 👁 2 views
Direct Source Verification: This story is aggregated from Reuters (reuters.com). Full reporting rights and copyright belong to the primary publisher.
Read on Reuters ↗
Novo says Ozempic shows lower risk of cardiovascular events compared to Lilly's Mounjaro  Reuters
Novo says Ozempic shows lower risk of cardiovascular events compared to Lilly's Mounjaro  Reuters
Original Source
https://news.google.com/rss/articles/CBMiwwFBVV95cUxOaS1SSkdZc2FMVFByTTMzdE5KSmJxZVNzU3NSN0MyNzgwemxXZ3lPdnFjQ3FNOHhWQkZ1dEFIYV9YYTJYWGNTUE5Qd0NOMVctMDBOZWw0bVhKcVhVYncwbzBRbnJxa2t0dWkzNTVZaS1Qb0FoN1NZVTMwcVdLQVFZcEpsY0RjZS1nSkdka2pMYjVwenVadGdwNHdQNFFWRVFwU19TU0l6V2pFaTY5cncxMHc4RDRGV01mZkhNUkNuMFZVTm8?oc=5
Visit Reuters ↗
SHARE STORY:
𝕏 f in

Related Coverage in Technology